Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$32.09 - $37.51 $802 - $937
25 Added 0.37%
6,850 $227,000
Q1 2023

Apr 27, 2023

BUY
$39.39 - $51.28 $47,110 - $61,330
1,196 Added 21.25%
6,825 $278,000
Q4 2022

Jan 17, 2023

SELL
$41.75 - $54.5 $104,375 - $136,250
-2,500 Reduced 30.75%
5,629 $288,000
Q3 2022

Oct 27, 2022

BUY
$43.76 - $53.42 $87,520 - $106,840
2,000 Added 32.63%
8,129 $356,000
Q2 2022

Jul 22, 2022

BUY
$46.53 - $55.17 $9,306 - $11,034
200 Added 3.37%
6,129 $321,000
Q3 2021

Oct 18, 2021

BUY
$39.25 - $50.42 $30,065 - $38,621
766 Added 14.84%
5,929 $255,000
Q2 2021

Jul 29, 2021

BUY
$35.91 - $40.68 $185,403 - $210,030
5,163 New
5,163 $202,000
Q1 2021

Apr 26, 2021

SELL
$33.49 - $37.77 $257,370 - $290,262
-7,685 Closed
0 $0
Q4 2020

Jan 28, 2021

SELL
$33.47 - $42.56 $32,298 - $41,070
-965 Reduced 11.16%
7,685 $282,000
Q3 2020

Nov 23, 2020

SELL
$31.75 - $37.25 $8,572 - $10,057
-270 Reduced 3.03%
8,650 $317,000
Q2 2020

Jul 23, 2020

BUY
$30.12 - $36.54 $268,670 - $325,936
8,920 New
8,920 $291,000
Q1 2020

Apr 07, 2020

SELL
$27.03 - $38.62 $186,371 - $266,284
-6,895 Closed
0 $0
Q4 2019

Feb 03, 2020

SELL
$32.92 - $37.36 $6,287 - $7,135
-191 Reduced 2.7%
6,895 $270,000
Q3 2019

Oct 24, 2019

SELL
$32.49 - $42.13 $116,639 - $151,246
-3,590 Reduced 33.63%
7,086 $254,000
Q2 2019

Jul 26, 2019

SELL
$36.98 - $41.52 $45,152 - $50,695
-1,221 Reduced 10.26%
10,676 $461,000
Q1 2019

Apr 17, 2019

BUY
$37.5 - $41.2 $76,687 - $84,254
2,045 Added 20.76%
11,897 $505,000
Q4 2018

Jan 28, 2019

BUY
$38.47 - $43.86 $108,408 - $123,597
2,818 Added 40.06%
9,852 $429,000
Q3 2018

Oct 09, 2018

SELL
$34.47 - $41.81 $5,032 - $6,104
-146 Reduced 2.03%
7,034 $309,000
Q3 2017

Nov 06, 2017

BUY
$31.0 - $34.15 $222,580 - $245,197
7,180
7,180 $256,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bank Of Stockton Portfolio

Follow Bank Of Stockton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Stockton, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Stockton with notifications on news.